001482380 000__ 05905cam\\22005777a\4500
001482380 001__ 1482380
001482380 003__ OCoLC
001482380 005__ 20231128003334.0
001482380 006__ m\\\\\o\\d\\\\\\\\
001482380 007__ cr\un\nnnunnun
001482380 008__ 231014s2023\\\\sz\\\\\\o\\\\\000\0\eng\d
001482380 019__ $$a1402247231
001482380 020__ $$a9783031362613$$q(electronic bk.)
001482380 020__ $$a3031362616$$q(electronic bk.)
001482380 020__ $$z3031362608
001482380 020__ $$z9783031362606
001482380 0247_ $$a10.1007/978-3-031-36261-3$$2doi
001482380 035__ $$aSP(OCoLC)1402813475
001482380 040__ $$aEBLCP$$beng$$cEBLCP$$dYDX$$dGW5XE$$dEBLCP$$dYDX$$dOCLCO$$dOCLCF
001482380 049__ $$aISEA
001482380 050_4 $$aRC280.L5$$bT73 2023
001482380 08204 $$a616.99/436061$$223/eng/20231024
001482380 24500 $$aTransarterial chemoembolization (TACE) /$$cPierleone Lucatelli, editor.
001482380 260__ $$aCham :$$bSpringer,$$c2023.
001482380 300__ $$a1 online resource (153 p.)
001482380 500__ $$aDEM-TACE for Colorectal Cancer Liver Metastases
001482380 5050_ $$aIntro -- Foreword -- Preface -- Contents -- 1: Rationale, Definition, and History of Transarterial Chemoembolization -- 1.1 From 60 S to Late 70 S: From Diagnostic to Therapeutic Arteriography -- 1.2 From Late 70 S: The Conventional TACE -- 1.3 From the 80 S: Degradable Starch Microsphere TACE -- 1.4 The 90 S-2000: Evidences on TACE -- 1.5 From Early 2000: Drug-Eluting Beads TACE -- 1.6 From 2008 to Nowadays -- References -- 2: Transarterial Chemoembolization (TACE): Indications -- 2.1 Introduction -- 2.2 TACE for Intermediate- Stage HCC -- 2.3 TACE for Non-intermediate-Stage HCC
001482380 5058_ $$a2.4 TACE for Bridging and Downstaging HCC to LT -- 2.5 TACE for Liver-Dominant Primary Cholangiocellular and Metastatic Disease -- References -- 3: Access and Material -- 3.1 Access -- 3.2 Materials and Technique -- 3.2.1 Novel Anti-Reflux Microcatheters. Pressure-Assisted Embolization -- References -- 4: Preprocedure Workup -- 4.1 Preprocedure Workup -- 4.1.1 Outpatient Examination -- 4.1.1.1 ECOG Performance Status -- 4.1.1.2 Laboratory Test -- 4.1.1.3 Imaging -- 4.1.1.4 Echocardiogram -- 4.1.1.5 Scores for Initial TACE -- 4.2 Periprocedure Workup -- 4.2.1 Medications
001482380 5058_ $$a4.2.2 Patient Management and Monitoring -- 4.2.3 Expert Nurse Team -- References -- 5: CBCT and Software -- 5.1 CBCT -- 5.1.1 Introduction -- 5.1.2 Technique Principles -- 5.1.3 Patient Preparation -- 5.1.4 Radiation Dose Principle and Concern -- 5.1.5 Application in Transarterial Chemoembolization -- 5.1.5.1 CBCT during Hepatic Artery Injection -- 5.1.5.2 Dual-Phase CBCT -- 5.1.5.3 CBCT without Contrast Media -- 5.1.5.4 CBCT during Portography -- 5.1.5.5 CBCT Perfusion -- 5.1.5.6 Potential Clinical Implication of CBCT -- 5.2 Software Guidance -- 5.2.1 Introduction
001482380 5058_ $$a5.2.2 Applications -- 5.2.2.1 Conclusion -- References -- 6: Conventional TACE (cTACE) -- 6.1 HCC -- 6.1.1 Conventional TACE in HCC: Technique and Standardised Protocol -- 6.1.1.1 Haemodynamics in the Liver and HCC -- 6.1.1.2 Conventional TACE (cTACE) Protocol -- 6.1.1.3 Chemotherapeutic Agents -- 6.1.1.4 Embolic Agents -- 6.2 Conventional TACE (cTACE) Technique: Superselective TACE -- 6.2.1 Limitation of TACE and Necessity for Curative TACE -- 6.3 Conventional TACE in Intrahepatic Cholangiocarcinoma (ICC) -- 6.3.1 Background -- 6.3.2 Clinical Evidence and Tumour Response
001482380 5058_ $$a6.3.3 Conventional TACE in Liver Metastases -- 6.3.3.1 From Colorectal Tumours (CRLM) -- 6.3.3.2 From Neuroendocrine Tumours (NETs) -- 6.3.3.3 From Other Types of Tumours -- References -- 7: Drug-Eluting Embolic TACE (DEB-TACE) -- 7.1 TACE with Drug-Eluting Microspheres (DEM-TACE) -- 7.1.1 DEM-TACE in Hepatocellular Carcinoma -- 7.1.1.1 Drugs -- 7.1.1.2 Bead Size -- 7.1.1.3 Procedural Specifications -- 7.1.1.4 Results -- 7.1.1.5 Bland Embolization Versus TACE and Treatment Endpoint -- 7.1.2 DEM-TACE in Other Tumors -- 7.1.2.1 DEM-TACE for Intrahepatic Cholangiocarcinoma
001482380 506__ $$aAccess limited to authorized users.
001482380 520__ $$aThe book thoroughly presents Transarterial Chemoembolization (TACE), a procedure representing the standard of care for several clinical oncological indications. Thanks to the considerable technological advances in the available instrumentation (guidewire, microcatheter, guiding imaging modalities) as well as the different platforms utilized to perform treatment (conventional TACE, drug eluted TACE, degradable starch microsphere TACE) indication for treatment has been broadened and results significantly improved. By clearly depicting the procedure, with technical details, advantages and limitations, the book provides a unique and most updated source on TACE procedures. Clinical cases regarding crucial parts of the procedure are also provided. Expert users as well as novel clinicians interested in the most recent aspects of this interventional radiology procedure will find in this book a valuable tool and guide for their clinical routine.
001482380 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed October 24, 2023).
001482380 650_6 $$aRadiologie interventionnelle.
001482380 650_6 $$aFoie$$xCancer$$xChimiothérapie.
001482380 650_6 $$aEmbolisation thérapeutique.
001482380 650_0 $$aInterventional radiology.$$0(DLC)sh 85110776
001482380 650_0 $$aLiver$$xCancer$$xChemotherapy.
001482380 650_0 $$aTherapeutic embolization.
001482380 655_0 $$aElectronic books.
001482380 7001_ $$aLucatelli, Pierleone.
001482380 77608 $$iPrint version:$$aLucatelli, Pierleone$$tTransarterial Chemoembolization (TACE)$$dCham : Springer International Publishing AG,c2023$$z9783031362606
001482380 852__ $$bebk
001482380 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-031-36261-3$$zOnline Access$$91397441.1
001482380 909CO $$ooai:library.usi.edu:1482380$$pGLOBAL_SET
001482380 980__ $$aBIB
001482380 980__ $$aEBOOK
001482380 982__ $$aEbook
001482380 983__ $$aOnline
001482380 994__ $$a92$$bISE